Athos Therapeutics has filed a notice of an exempt offering of securities to raise $34,999,995.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Athos Therapeutics is raising up to $34,999,995.00 in new funding. Sources indicate that as part of senior management President, Dimitrios Iliopoulos played a key role…